Domača stran2096 • HKG
add
Simcere Pharmaceutical Group Ltd
Prejšnji trg. dan.
6,53 $
Dnevni razpon
6,52 $ - 6,80 $
Letni razpon
4,94 $ - 7,87 $
Tržna kapitalizacija
17,11 mrd. HKD
Povprečni obseg
6,10 mio.
Razm. P/E
-
Dividendna donosnost
2,60 %
Primarna borza
HKG
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (CNY) | jun. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 1,56 mrd. | −7,93 % |
Stroški poslovanja | 939,63 mio. | −14,71 % |
Čisti dohodek | 228,30 mio. | −79,92 % |
Čista dobičkovnost prihodkov | 14,66 | −78,19 % |
Earnings per share | — | — |
EBITDA | 345,55 mio. | 47,98 % |
Efektivna davčna stopnja | 7,70 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (CNY) | jun. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 3,06 mrd. | 24,38 % |
Skupna sredstva | 11,71 mrd. | −7,70 % |
Skupne obveznosti | 4,80 mrd. | 32,12 % |
Celoten lastniški kapital | 6,91 mrd. | — |
Shares outstanding | 2,54 mrd. | — |
Razmerje P/B | 2,40 | — |
Donosnost sredstev | 6,22 % | — |
Donosnost kapitala | 9,00 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (CNY) | jun. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 228,30 mio. | −79,92 % |
Denar iz dejavnosti | 431,33 mio. | 1.152,84 % |
Denar iz naložb | −200,98 mio. | −129,73 % |
Denar iz financiranja | 143,27 mio. | 159,16 % |
Neto sprememba denarnih sredstev | 373,91 mio. | −5,19 % |
Prost denarni tok | 215,87 mio. | 112,26 % |
Vizitka
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The Company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
Generalni direktor
Datum ustanovitve
1995
Sedež organizacije
Spletno mesto
Zaposleni
6.412
